Cereus Biosciences Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

Cereus Biosciences General Information

Description

Developer of therapeutic cancer vaccines intended to provide off-the-shelf immunotherapy. The company offers dark genome exploration, shared neoantigen identification, off-the-shelf vaccine formulation, proprietary diva platforms, kneo-max analysis engines, and unreferenced in silico exploration, enabling healthcare providers and pharmaceutical partners to access therapeutic cancer vaccines, neoantigen collections, diagnostic algorithms, vaccine vectors, clinical trial candidates, and research licenses.

Contact Information

Website
cereus.bio
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 23 Rue Galilée
  • 75016 Paris
  • France
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Corporate Office
  • 23 Rue Galilée
  • 75016 Paris
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cereus Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 22-Jun-2026 Completed Generating Revenue
2. Accelerator/Incubator 01-Oct-2024 Completed Generating Revenue
1. Spin-Off 30-Mar-2023 Completed Generating Revenue
To view Cereus Biosciences’s complete valuation and funding history, request access »

Cereus Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cereus Biosciences Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Paris-Saclay Cancer Cluster Accelerator/Incubator
Institut Curie Incubation Program Accelerator/Incubator
To view Cereus Biosciences’s complete investors history, request access »

Cereus Biosciences FAQs

  • When was Cereus Biosciences founded?

    Cereus Biosciences was founded in 2023.

  • Where is Cereus Biosciences headquartered?

    Cereus Biosciences is headquartered in Paris, France.

  • What is the size of Cereus Biosciences?

    Cereus Biosciences has 3 total employees.

  • What industry is Cereus Biosciences in?

    Cereus Biosciences’s primary industry is Biotechnology.

  • Is Cereus Biosciences a private or public company?

    Cereus Biosciences is a Private company.

  • What is Cereus Biosciences’s current revenue?

    The current revenue for Cereus Biosciences is .

  • Who are Cereus Biosciences’s investors?

    Paris-Saclay Cancer Cluster and Institut Curie Incubation Program have invested in Cereus Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process